Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Assets (2016 - 2025)

Historic Assets for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $874.7 million.

  • Tandem Diabetes Care's Assets fell 867.44% to $874.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $874.7 million, marking a year-over-year decrease of 867.44%. This contributed to the annual value of $967.7 million for FY2024, which is 157.45% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Assets of $874.7 million as of Q3 2025, which was down 867.44% from $875.7 million recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Assets high stood at $1.1 billion for Q4 2022, and its period low was $754.3 million during Q1 2021.
  • Over the past 5 years, Tandem Diabetes Care's median Assets value was $941.0 million (recorded in 2024), while the average stood at $933.0 million.
  • In the last 5 years, Tandem Diabetes Care's Assets skyrocketed by 11969.52% in 2021 and then tumbled by 1027.29% in 2023.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Assets stood at $905.1 million in 2021, then rose by 16.31% to $1.1 billion in 2022, then fell by 9.51% to $952.7 million in 2023, then rose by 1.57% to $967.7 million in 2024, then fell by 9.61% to $874.7 million in 2025.
  • Its last three reported values are $874.7 million in Q3 2025, $875.7 million for Q2 2025, and $922.1 million during Q1 2025.